Trademark: 90839564
Status Date
Monday, February 19, 2024
Filing Date
Wednesday, July 21, 2021
Published for Opposition
Tuesday, May 24, 2022
Abandoned Date
Monday, February 19, 2024
5 Pharmaceuticals for the treatment and prevention of cancer; Pharmaceuticals for use in conjunction with multi-modal therapies for treatment of neuroblastoma
35 Promoting public awareness of the need for research for the diagnosis, treatment, and development of a cure for childhood cancer, in particular pediatric neuroblastoma
Feb 20, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 19, 2024
Abandonment - No Use Statement Filed
Oct 22, 2023
Teas Change Of Correspondence Received
Oct 22, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 22, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 29, 2023
Sou Extension 2 Granted
Jun 29, 2023
Sou Extension 2 Filed
Jun 29, 2023
Sou Teas Extension Received
Jan 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 5, 2023
Sou Extension 1 Granted
Jan 5, 2023
Sou Extension 1 Filed
Jan 5, 2023
Sou Teas Extension Received
Jul 19, 2022
Noa E-Mailed - Sou Required From Applicant
May 24, 2022
Official Gazette Publication Confirmation E-Mailed
May 24, 2022
Published For Opposition
May 4, 2022
Notification Of Notice Of Publication E-Mailed
Apr 18, 2022
Law Office Publication Review Completed
Apr 15, 2022
Approved For Pub - Principal Register
Apr 14, 2022
Assigned To Examiner
Oct 5, 2021
Preliminary/Voluntary Amendment - Entered
Oct 4, 2021
Assigned To Lie
Jul 29, 2021
Teas Voluntary Amendment Received
Sep 22, 2021
New Application Office Supplied Data Entered
Jul 24, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
